References

Acar, J.F., 1997. Consequences of bacterial resistance to antibiotics in medical practice. Clin. Infect. Dis., 24: 17-18.
PubMed  |  

Bradford, P.A., 2001. Extended spectrum β-lactamase in the 21st century: Characterization epidemiology and detections of this important resistant threat. Clin. Microb. Rev., 48: 933-951.
CrossRef  |  

Bush, K., G.A. Jacoby and A.A. Medeiros, 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother., 39: 1211-1233.
PubMed  |  Direct Link  |  

Chessbrough, M., 2000. District Laboratory Practice in Tropical Countries. 2nd Edn., Cambridge University Press, UK., ISBN-0-521-66546-9, pp: 178-187.

Cohen, M.L., 1992. Epidemiology of drug resistance: Implications for a post-antimicrobial era. Science, 257: 1050-1055.
CrossRef  |  PubMed  |  

Essack, S.Y., L.M. Hall, D.G. Pillay, M.L. Mcfadyen and D.M. Livermore, 2001. Complexity and diversity of Klebsiella pneumoniae strains with extended β-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban South Africa. Antimicrob. Agents Chemother., 45: 88-95.
CrossRef  |  

Kariuki, S., J.E. Corkill, G. Revathi, R. Musoke and C.A. Hart, 2001. Molecular characterization of a novel plasmid-encoded cafotaxime (CTX-M-12) found in clinical isolates of K. pneumoniae isolated from Kenya. Antimicrob. Agent Chemother., 45: 2141-2143.
CrossRef  |  

Kim, Y.K., H. Pai, H.J. Lee, S.E. Park, E.H. Choi, J. Kim, J.H. Kim and E.C. Kim, 2002. Blood stream infections by extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae in children: Epidemiology and clinical outcome. Antimicrob. Agents Chemother., 46: 1481-1491.
CrossRef  |  PubMed  |  

Knothe, H., P. Shah, V. Kremey, N. Antal and S. Mitsuhashi, 1983. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of K. pneumoniae and Serretia marcescens. Infection, 11: 315-317.
PubMed  |  

Moosden, F., 1997. The evolution of resistance to cephalorporins. Clin. Infect. Dis., 24: 487-493.
PubMed  |  

Olusegun, O.S., Q.A. Marie, K.O. Kayode, A.A. Bolanle and C.R. Marilyn, 2005. CTX-M-15 extended-spectrum β-lactamase from Nigeria Klebsiella Pneumoniae. J. Antimicrob. Chemother., 57: 24-30.
CrossRef  |  

Paterson, D.L., L. Mulazimogu, J.M. Casellas, W.C. Ko and H. Goossens et al., 2000. Epidemiology of ciprofloxacin resistance and its relationship to extended spectrum β-lactamase production in Klebsiella pneumoniae causing bacteremia. Clin. Infect. Dis., 30: 473-478.
PubMed  |  

Shannon, K.P., A. King, I. Phillips, M.H. Nicolas and A. Phillippon, 1990. Importance of organisms producing broad-spectrum SHV-group β-lactamases into the United Kingdom. J. Antimicrob. Chemother., 25: 343-351.
PubMed  |  

Shiappa, D.A., M.K. Hayden and M.G. Matuhek, 1996. Ceftazidime resistant Klebsiella pneumoniae and Escherichia coli blood stream infections: A case control and molecular epidemiologic investigatio. J. Infect. Dis., 174: 529-536.
PubMed  |  

Sow, A.I., R. Diagne, M.F. Cisse, M.N. Dia and K.O. Sy et al., 1997. Infections nosocomiales a Klebsiella pneumonia au CHU de Fann, Dakar. Dakar Med., 42: 40-43.

Tenover, F.C. and J.M. Hugles, 1996. The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacteria pathogens. J. Am. Med. Assoc., 275: 300-304.
PubMed  |